AI Analysis of Wearable Blood Pressure Data May Flag Hypertensive Crises Up to Three Days Ahead

312 of more than 4,000 participants experienced 418 hypertensive crises, a medical emergency that can lead to stroke, heart attack, kidney damage, aortic dissection or pulmonary edema.
A single reading only captures one moment in time
Lead author Chaudhry explains why continuous tracking was tested for predicting hypertensive crises.
Mark

What's the headline claim here?

Mimi

That AI analysis of continuous blood pressure and wearable data could flag, up to three days ahead, which patients with stage 2 hypertension were headed toward a crisis.

Mark

How often was an alert right?

Mimi

About 32% of alerted patients had a crisis. And 97.4% of those with no alert stayed crisis-free.

Luke

So most alerts were not followed by a crisis. That's worth saying plainly, and it's a different thing from the tool being wrong, but it matters for clinician workload.

Mark

What patterns did the model lean on?

Mimi

Blood pressure that didn't dip during sleep carried nearly five times the odds. A rise of more than 35 mm Hg after waking carried nearly four times.

Mark

And the 61% drop in crises?

Mimi

That's among alerted patients whose medication was adjusted within 24 hours, compared with people who didn't get timely intervention. Emergency visits were about 45% lower.

Luke

Careful there. That's a comparison between groups, not necessarily a randomized test. The source doesn't say the groups were otherwise alike, so I wouldn't read it as proof the alerts caused the drop.

Mark

Who was studied?

Mimi

4,190 adults aged 40 to 85 at one hospital in Sindh, Pakistan, followed for a year.

Luke

One hospital, preliminary, presented but not yet described as peer reviewed. How it performs elsewhere is unknown, and so is the right protocol for responding to an alert.

  • A hypertensive crisis can strike without warning, and for many patients there are no symptoms before stroke, heart attack, or kidney damage follows.
  • The AI tool flags high-risk patients up to 72 hours ahead, but only about a third of alerted patients actually go on to have a crisis, so clinicians face real uncertainty about how to respond.
  • Physicians are now being asked to confirm readings, review symptoms and medication adherence, and decide quickly whether to adjust treatment or send a patient for emergency care.
  • Among patients whose medications were changed within a day of an alert, crises fell by about 61% and emergency visits by about 45%, a promising signal from preliminary data.
  • The findings must still be tested across more diverse populations and healthcare systems before routine use, and standardized response protocols remain unsettled.

Blood pressure is usually measured as a single snapshot, and a single snapshot can miss what is building beneath it. In a preliminary study of more than four thousand adults in Sindh, Pakistan, researchers asked whether artificial intelligence reading a continuous stream of cuff and wearable data could sense a dangerous surge before it arrived. The early answer is cautiously hopeful: alerts often preceded crises by as much as three days, and when physicians acted quickly, the most frightening outcomes became less frequent. Yet the work remains a single-hospital beginning, and medicine must still learn how best to answer the warning it has been given.

A single blood pressure reading captures one moment, and that limitation is what a team of researchers set out to address. They followed 4,190 adults with stage 2 hypertension, all treated at one hospital in Sindh, Pakistan, from January 2025 to January 2026, asking whether artificial intelligence fed a steady stream of blood pressure and wearable data could see a hypertensive crisis coming. The participants, averaging 62 years old, wore portable cuff monitors that measured pressure through the day and night, along with wrist devices tracking heart rate and its variability.

The AI examined 47 characteristics of this data and searched for patterns that preceded a crisis within 72 hours. When the model raised an alert, the physician contacted the patient, reviewed symptoms, and adjusted medication if needed. Over the year, 312 participants experienced 418 crises. About 32% of alerted patients went on to have one, while 97.4% of those never flagged stayed crisis-free. Two patterns stood out: pressure that failed to dip during sleep, and a rise of more than 35 mm Hg after waking, were each linked to markedly higher odds of an upcoming crisis.

The most encouraging figure came from patients whose physicians acted within 24 hours of an alert. Their crises fell by about 61%, and emergency visits by about 45%. Researchers and outside specialists alike stressed that these tools should complement, not replace, clinical judgment, and that the work must be tested in more diverse populations and settings before wide adoption. Until then, the authors suggest, the warning is promising but its full meaning is still being learned.

A single blood pressure reading is a snapshot of one moment. That is the problem a team of researchers set out to address in a study of 4,190 adults with stage 2 hypertension, all treated at one hospital in Sindh, Pakistan, and followed from January 2025 to January 2026. The question was whether artificial intelligence, fed a steady stream of blood pressure and wearable data, could see a hypertensive crisis coming before it arrived.

The findings are preliminary and independent, and they will be presented at the American Heart Association's Scientific Sessions 2026, held Nov. 6-9 in Chicago. The participants were ages 40 to 85, with an average age of 62.4, and 46% were women. Each wore a portable cuff-based blood pressure monitor that took repeated readings through the day and night, including during daily activities and sleep. They also wore a wrist device with light-based sensors that tracked cardiovascular signals such as heart rate and heart rate variability.

Researchers analyzed 47 characteristics in that data, among them how much blood pressure dropped during sleep, how much it rose after waking, how it changed over time, and how heart rate varied. An AI tool then looked for combinations of patterns linked to a hypertensive crisis within the next 72 hours. A crisis here means readings above 180/120 mm Hg together with acute end-organ damage. It can lead to stroke, heart attack, kidney damage, aortic dissection or pulmonary edema, and it is a leading cause of heart-related emergency department visits. When the model flagged a patient, the physician was alerted, contacted the patient, reviewed symptoms and adjusted medication if needed.

Over the 12 months, 312 participants, about 7% of the total, had 418 hypertensive crises. The tool could separate higher-risk from lower-risk patients up to 72 hours ahead. Among those who triggered an alert, about 32% went on to have a crisis, while 97.4% of those with no alert stayed crisis-free.

Two patterns stood out. Participants whose blood pressure did not fall during sleep, as it normally should, had nearly five times the odds of an upcoming crisis. Those whose pressure climbed more than 35 mm Hg after waking, compared with nighttime levels, had nearly four times the odds.

The intervention numbers drew attention too. Among patients whose physicians received an alert and adjusted medication within 24 hours, hypertensive crises were about 61% lower and emergency department visits about 45% lower than in people who did not get timely, alert-triggered intervention. "Everyone's blood pressure changes throughout the day and night, and a single reading only captures one moment in time," said lead author Waleed Razzaq Chaudhry, M.D., an internal medicine resident at the University of Maryland Capital Region Medical Center in Largo. He said earlier detection could give patients and clinicians more time to act.

Maria Delgado-Lelievre, M.D., a hypertension specialist at the University of Miami Miller School of Medicine, noted that many patients have no warning symptoms before a serious complication. She said such tools should complement, not replace, clinical decision-making.

The limits are plain. Every participant was an adult in Pakistan treated at a single hospital, and the researchers say the approach must be tested in more diverse groups and healthcare settings before wide use. More work is also needed on how clinicians should respond to a high-risk alert: confirming pressure, reviewing symptoms and medication adherence, deciding on adjustment, and judging when emergency evaluation is warranted. A 2025 AHA scientific statement said cuffless devices need more research and standardized testing before guiding care. The Association recommends automatic upper-arm cuff monitors, not wrist or finger devices, and lists validated models at validatebp.org.

Continuous blood pressure monitoring can help detect these changes earlier, which may give patients and clinicians more time to act before it becomes an emergency.
— Waleed Razzaq Chaudhry, M.D., lead study author
Digital health technologies should complement, not replace, clinical decision-making in hypertension care.
— Maria Delgado-Lelievre, M.D., University of Miami Miller School of Medicine
Quer a matéria completa? Leia o original em News-Medical ↗
Fale Conosco FAQ